Health Care Emerges as Defensive Haven as AI Trade Stumbles, Investors Rotate In Nov 13, 2026 Life Science, Technology
What Eli Lilly’s China Approval for Oral GLP-1 Weight-Loss Drug Means for Investors Nov 12, 2026 Life Science
Viking Therapeutics Emerges as Potential Dark Horse in Weight-Loss Drug Race Amid Eli Lilly’s Dominance Nov 11, 2026 Life Science
Novo Nordisk’s 2026 Transition Year: Early Wegovy Pill Success Meets Weak Earnings and a Stock Down 20% Over Five Years Nov 8, 2026 Life Science
Moderna Returns to Profit After Two Years, Sparking Valuation Debate on 720% 2026 Surge Nov 6, 2026 Life Science
AbbVie, a Dividend King, Builds Its Next Blockbuster as ABBV-466 Hits Phase 2 Milestone Nov 2, 2026 Life Science
CareDx Shares Surge 22.2% After Blowout Third-Quarter Results, Raised 2026 Guidance Oct 30, 2026 Life Science
After a Blistering Rally, Is Revolution Medicines Still a Compelling Value Play? Oct 27, 2026 Life Science
ESMO Readouts Steal the Spotlight, These Three Oncology Stocks Don’t Need the Podium Oct 26, 2026 Life Science
AbbVie Prepares to Cross Its Patent Cliff as Successor Pipeline Takes Shape Oct 22, 2026 Life Science
AstraZeneca and Oracle AI Trial Pact: Can the Partnership Reset the Market’s Pricing? Oct 20, 2026 Life Science, Technology
Will Third-Quarter Earnings Be the Turning Point for These Two Lagging Healthcare Stocks? Oct 14, 2026 Life Science
Forget FOMO on Surging Stocks — These 3 Out-of-Favor Names Are the Smarter Bet Oct 13, 2026 Consumer Goods, Life Science, Technology
Bristol Myers Squibb’s Zenbexus Posts Win in Phase 3 Trial, What It Means for Investors Oct 9, 2026 Life Science
